mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production.
mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production.
复制标题
DOI:
10.4049/jimmunol.1501541
复制
发表时间:
2016-05-15
期刊:
影响因子:
--
通讯作者:
Cong Y
中科院分区:
文献类型:
--
作者:
Chen F;Cao A;Yao S;Evans-Marin HL;Liu H;Wu W;Carlsen ED;Dann SM;Soong L;Sun J;Zhao Q;Cong Y
It has been shown recently that neutrophils are able to produce IL-22 and IL-17, which differentially regulate the pathogenesis of inflammatory bowel disease (IBD). However, it is still largely unknown how the neutrophil production of IL-22 and IL-17 is regulated, and their role in the pathogenesis of IBD. In this study, we found that IL-23 promoted neutrophil production of IL-17 and IL-22. IL-23 stimulated the neutrophil expression of IL-23 receptor as well as rorc and ahr. RORγt and AhR differentially regulated IL-23 induction of neutrophil IL-17 and IL-22. Additionally, IL-23 induced the activation of mTOR in neutrophils. Blockade of mTOR pathway inhibited IL-23-induced expression of rorc and ahr as well as IL-17 and IL-22 production. By utilizing a microbiota antigen specific T-cell mediated colitis model, we demonstrated that depletion of neutrophils, as well as blockade of IL-22, resulted in a significant increase in the severity of colitis, thereby indicating a protective role of neutrophils and IL-22 in chronic colitis. Collectively, our data revealed that neutrophils negatively regulate microbiota antigen specific T cell induction of colitis, and IL-23 induces neutrophil production of IL-22 and IL-17 through induction of rorc and ahr, which is mediated by mTOR pathway.